Our goal is to optimize the therapeutic potential of oligonucleotides by enhancing their functional delivery to all tissues in the body.
Initos Pharmaceuticals LLC is presenting as part of the NIH Innovation Zone.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
splice switching oligonucleotides
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):